N43CO120036-000 (N43) | |||
---|---|---|---|
Title | Topic 301, Pharmaco-Kinesis Corporation Phase I entitled "A VEGF Nanosensor to Mo | ||
Institution | PHARMACO-KINESIS CORPORATION, INGLEWOOD, CA | ||
Principal Investigator | CURRELI, MARCO | NCI Program Director | N/A |
Cancer Activity | N/A | Division | N/A |
Funded Amount | $170,009 | Project Dates | 09/28/2012 - 06/27/2013 |
Fiscal Year | 2012 | Project Type | Contract |
Research Topics w/ Percent Relevance | Cancer Types w/ Percent Relevance | ||
Cancer (100.0%) | Brain (100.0%) | ||
Research Type | |||
Technology and/or Marker Evaluation With Respect to Fundamental Parameters of Method Systemic Therapies - Discovery and Development |
|||
Abstract | |||
No abstract available. |